fluoxetine has been researched along with Lung Diseases, Interstitial in 6 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Excerpt | Relevance | Reference |
|---|---|---|
| "36 cases of interstitial lung disease related to fluoxetine were retrieved from the VigiAccess database (updated to July 2016), and 36 reports were found in EudraVigilance database (updated to June 2016)." | 2.55 | Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database. ( Bocchetta, A; Deidda, A; Del Zompo, M; Micheletto, L; Pisanu, C; Stochino, ME, 2017) |
| "Fluoxetine treatment effects were determined by evaluating respiratory mechanics (elastance/resistance) and exhaled nitric oxide, as well as mononuclear and polymorphonuclear cell recruitment into the lungs, in an experimental guinea pig model." | 1.34 | Morphological and functional determinants of fluoxetine (Prozac)-induced pulmonary disease in an experimental model. ( Capelozzi, MA; Capelozzi, VL; Leick-Maldonado, EA; Martins, MA; Parra, ER; Tibério, IF, 2007) |
| "Fluoxetine (Prozac) is a new anti-depressant introduced on the marked in France since 1989." | 1.30 | [Interstitial lung disease linked to fluoxetine]. ( Lamblin, C; Vandezande, LM; Wallaert, B, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Wen, C | 1 |
| He, T | 1 |
| Liu, B | 1 |
| Deidda, A | 1 |
| Pisanu, C | 1 |
| Micheletto, L | 1 |
| Bocchetta, A | 1 |
| Del Zompo, M | 1 |
| Stochino, ME | 1 |
| Capelozzi, MA | 1 |
| Leick-Maldonado, EA | 1 |
| Parra, ER | 1 |
| Martins, MA | 1 |
| Tibério, IF | 1 |
| Capelozzi, VL | 1 |
| Miller, LG | 1 |
| Vandezande, LM | 1 |
| Lamblin, C | 1 |
| Wallaert, B | 1 |
| Braun, D | 1 |
| Nippert, B | 1 |
| Loeuille, D | 1 |
| Blain, H | 1 |
| Tréchot, P | 1 |
1 review available for fluoxetine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database.
Topics: Animals; Antidepressive Agents; Databases, Factual; Fluoxetine; Humans; Lung; Lung Diseases, Interst | 2017 |
5 other studies available for fluoxetine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Identifying interstitial lung disease associated chemicals by integrating transcriptome-wide association study and chemical-gene interaction networks.
Topics: Cholecalciferol; Fluoxetine; Humans; Lung Diseases, Interstitial; Quality of Life; Transcriptome | 2023 |
Morphological and functional determinants of fluoxetine (Prozac)-induced pulmonary disease in an experimental model.
Topics: Airway Resistance; Animals; Antidepressive Agents, Second-Generation; Bronchoconstriction; Disease M | 2007 |
I have read about a patient in whom fluoxetine use may have caused lung damage. Can you comment on the likelihood that there was a cause and effect relationship in this published case?
Topics: Dose-Response Relationship, Drug; Fluoxetine; Humans; Lung Diseases, Interstitial; Risk Factors | 1993 |
[Interstitial lung disease linked to fluoxetine].
Topics: Aged; Antidepressive Agents, Second-Generation; Bronchoalveolar Lavage Fluid; Fluoxetine; Humans; Lu | 1997 |
[Interstitial pneumopathy induced by fluoxetine].
Topics: Adult; Antidepressive Agents, Second-Generation; Dyspnea; Female; Fluoxetine; Humans; Lung Diseases, | 1999 |